Is hormone replacement therapy-related breast cancer more favorable? A case-control study

被引：6

作者：

Khan, Hamed N. ^{[1
]}

Bendall, Susan ^{[1
]}

Bates, Tom ^{[1
]}

机构：

[1] William Harvey Hosp, Dept Surg, Breast Unit, Ashford, Kent, England

来源：

BREAST JOURNAL | 2007年 / 13卷 / 05期

关键词：

breast cancer; hormone replacement therapy; prognosis; survival;

D O I：

10.1111/j.1524-4741.2007.00471.x

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Hormone replacement therapy (HRT)-related breast cancer may carry a better prognosis since there is no increase in breast cancer deaths. We looked at the prognostic risk factors and outcome inpatients who had ever taken HRT compared to those who had not, in a case control study. Subgroups of recent-users and those using HRT for >5 years were also compared to controls. Tumor size, grade, vascular invasion, lymph node, and estrogen receptor status as well as median Nottingham Prognostic Indicator (NPI) were compared between cases and controls. Absolute survival between ever-users and never-users was compared by life table analysis. There was no difference between all the cases and their controls for the five prognostic factors. NPI in each group was also similar. Absolute survival between ever-users and never-users was not significantly different either (p = 0.678). There was no evidence that HRT-related breast cancer has a more favorable outcome.

引用

页码：496 / 500

页数：5

共 50 条

[11] Hormone replacement therapy after menopause and risk of breast cancer in BRCA1 mutation carriers: a case-control study
Kotsopoulos, Joanne
Huzarski, Tomasz
Gronwald, Jacek
Moller, Pal
Lynch, Henry T.
Neuhausen, Susan L.
Senter, Leigha
Demsky, Rochelle
Foulkes, William D.
Eng, Charis
Karlan, Beth
Tung, Nadine
Singer, Christian F.
Sun, Ping
Lubinski, Jan
Narod, Steven A.
BREAST CANCER RESEARCH AND TREATMENT, 2016, 155 (02) : 365 - 373
[12] Case control study of hormone replacement therapy (HRT) and breast cancer in Japanese women.
Takeuchi, M.
Saeki, T.
Sano, M.
Sonoo, H.
Honjo, H.
Ochiai, K.
Sugano, H.
Komiike, Y.
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 544S - 544S
[13] A retrospective case-control study of the use of hormone-related supplements and association with breast cancer
Rebbeck, Timothy R.
Troxel, Andrea B.
Norman, Sandra
Bunin, Greta R.
DeMichele, Angela
Baumgarten, Mona
Berlin, Michelle
Schinnar, Rita
Strom, Brian L.
INTERNATIONAL JOURNAL OF CANCER, 2007, 120 (07) : 1523 - 1528
[14] Hormone replacement therapy and ischemic stroke severity in women - A case-control study
Bushnell, CD
Samsa, GP
Goldstein, LB
NEUROLOGY, 2001, 56 (10) : 1304 - 1307
[15] Hormone replacement therapy and cataract: a population-based case-control study
Aina, FO
Smeeth, L
Hubbard, R
Hurt, LS
Fletcher, AE
EYE, 2006, 20 (04) : 417 - 422
[16] Hormone replacement therapy and risk of glioma: A nationwide nested case-control study
Andersen, Lene
Friis, Soren
Hallas, Jesper
Ravn, Pernille
Gaist, David
CANCER EPIDEMIOLOGY, 2013, 37 (06) : 876 - 880
[17] A case-control study on the effect of hormone replacement therapy on ischaemic heart disease
Hippisley-Cox, J
Pringle, M
Crown, N
Coupland, C
BRITISH JOURNAL OF GENERAL PRACTICE, 2003, 53 (488): : 191 - 196
[18] Case-control study of venous thromboembolism risk in users of hormone replacement therapy
Daly, E
Vessey, MP
Painter, R
Hawkins, MM
LANCET, 1996, 348 (9033): : 1027 - 1027
[19] Hormone replacement therapy, reproductive history, and colon cancer: A multicenter, case-control study in the United States
Kampman, E
Potter, JD
Slattery, ML
Caan, BJ
Edwards, S
CANCER CAUSES & CONTROL, 1997, 8 (02) : 146 - 158
[20] Hormone replacement therapy as a risk factor for epithelial ovarian cancer: Results of a case-control study - In reply
Hempling, RE
Wong, C
Piver, MS
Natarajan, N
Mettlin, CJ
OBSTETRICS AND GYNECOLOGY, 1997, 90 (04): : 642 - 642

← 1 2 3 4 5 →